/PRNewswire/ NanoMosaic, the pioneer and leader in nanoneedle (MosaicNeedle™) detection for proteomics and genomics, was invited to, and presented a talk,.
NanoMosaic Installs Wide Dynamic Range Proteomic Beta System at The New York Stem Cell Foundation Research Institute (NYSCF)
News provided by
Share this article
Share this article
NEW YORK, April 6, 2021 /PRNewswire/ NanoMosaic, the pioneer and leader in nanoneedle (MosaicNeedle™) detection for proteomics and genomics, has installed its end-user fully customizable, nanoneedle proteomic beta system, Tessie™, at its second test site, the New York Stem Cell Foundation Research Institute (NYSCF). Tessie
TM, is able to achieve seven orders of dynamic range interrogation at a competitive, lower price per-protein than commercially available systems. NYSCF, a global leader in translational stem cell research, will utilize the platform to further understand the proteomic profiles at various stages of stem cell differentiation.
NanoMosaic Installs Wide Dynamic Range Proteomic Beta System at The New York Stem Cell Foundation Research Institute (NYSCF) prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
BOSTON, Jan. 6, 2021 /PRNewswire/ BrickBio, the leading company in site-specific bioconjugation for improved therapeutics, has signed a deal with a large pharmaceutical partner to co-develop a therapeutic antibody drug conjugate (ADC). Financials and the split of therapeutic intellectual property were not disclosed.
BrickBio has a focused effort in the areas of oncology, neurology, and metabolic disease, although the company s established site-specific modification process is robust and expandable beyond the scope of these disease states. In addition to expanding its internal pipeline, the company has entered into a number of partnerships with top pharmaceutical companies and international partners within one year of the company moving into its laboratory space.